Cargando…
γ-Secretase in Alzheimer’s disease
Alzheimer’s disease (AD) is caused by synaptic and neuronal loss in the brain. One of the characteristic hallmarks of AD is senile plaques containing amyloid β-peptide (Aβ). Aβ is produced from amyloid precursor protein (APP) by sequential proteolytic cleavages by β-secretase and γ-secretase, and th...
Autor principal: | Hur, Ji-Yeun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076685/ https://www.ncbi.nlm.nih.gov/pubmed/35396575 http://dx.doi.org/10.1038/s12276-022-00754-8 |
Ejemplares similares
-
Turning the tide on Alzheimer’s disease: modulation of γ-secretase
por: Luo, Joanna E., et al.
Publicado: (2022) -
BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease
por: Maia, Miguel A., et al.
Publicado: (2019) -
Probing Mechanisms and Therapeutic Potential of γ-Secretase in Alzheimer’s Disease
por: Wolfe, Michael S.
Publicado: (2021) -
Innate immunity protein IFITM3 modulates γ-secretase in Alzheimer disease
por: Hur, Ji-Yeun, et al.
Publicado: (2020) -
Synaptic and Endosomal Localization of Active γ-Secretase in Rat Brain
por: Frykman, Susanne, et al.
Publicado: (2010)